MSKCC_SSit(@MSKCC_SSit) 's Twitter Profile Photo

This morning at our Surg Research Conference, Dr. Paul Romesser discusses translational models to study radiation therapy in gastrointestinal malignancies.

This morning at our Surg Research Conference, Dr. Paul Romesser discusses translational models to study radiation therapy in gastrointestinal malignancies. #mskcc #SSit #radiationtherapy #GImalignancies
account_circle
PeerView(@PeerView) 's Twitter Profile Photo

Join Yelena Y. Janjigian MD, Dr. Shubham Pant & Dr. Strickler as they discuss treatment plans with HER2-targeted therapies for & where these options fit in current guideline recommendations. 5/31 at 6:30 PM CDT at ! With @CureCC & Colorectal Cancer Alliance: bit.ly/2024GIT

account_circle
HILFIKER PR(@hilfikerpr) 's Twitter Profile Photo

Hurry up !! Register Now
Certified Medical Training: 3 Credits
🎯 GI Malignancies
⏱️ 3 december 2020
🚀 Webinar Live Interactive Training

hilfiker-pr.ch/dec2020/

Hurry up !! Register Now
Certified Medical Training: 3 Credits
🎯 GI Malignancies
⏱️ 3 december 2020
🚀 Webinar Live Interactive Training

hilfiker-pr.ch/dec2020/

#oncology #gimalignancies #medicaltraining #gastriccancer
account_circle
Brittany Rigacci(@BrittanyRigacci) 's Twitter Profile Photo

Shared updates from ASCO in with OncLive SOSS. Dr. Becerra also presented pancreatic CAR-T and NK cell therapy trials now offered at @BSWHealth_MED onclive.com/onclive-tv/dr-…

Shared updates from @ASCO in #gimalignancies with @OncLiveSOSS. Dr. Becerra also presented pancreatic CAR-T and NK cell therapy trials now offered at #BaylorDallas #stateofscience @BSWHealth_MED onclive.com/onclive-tv/dr-…
account_circle
Dr. Iván R. González(@Dr_Ivanoncologo) 's Twitter Profile Photo

Excellent review by PhD Morelli at about the landscape of immune bases approaches for and how novel immune check point inhibitors could provide synergistic effect with PD1/PD-L1 and CTLA-4 inhibitors, without increased toxicity.😁👏
ASCO

Excellent review by PhD Morelli at #ASCO23 about the landscape of immune bases approaches for #GImalignancies and how novel immune check point inhibitors could provide synergistic effect with PD1/PD-L1 and CTLA-4 inhibitors, without increased toxicity.😁👏
@ASCO
account_circle
AnnalsSurgOncology(@AnnSurgOncol) 's Twitter Profile Photo

Diagnostic Performance of AI-Centered Systems in the Diagnosis and Postoperative Surveillance of Upper Using CT Imaging: Review and Meta-Analysis Swathikan Chidambaram rdcu.be/cI722 Kelly McMasters, MD, PhD

Diagnostic Performance of AI-Centered Systems in the Diagnosis and Postoperative Surveillance of Upper #GIMalignancies Using CT Imaging: Review and Meta-Analysis  @cswathikan rdcu.be/cI722 #VisualAbstract @McMastersKelly
account_circle
donnashort(@donnashort) 's Twitter Profile Photo

Categories of include resectable, borderline resectable, and unresectable says Dr Zev Wainberg ⁦OncLive SOSS .⁩ big trials ongoing are the NCT, Alliance, and PRODIGE.

Categories of #pancreaticcancer include resectable, borderline resectable, and unresectable says Dr Zev Wainberg ⁦@OncLiveSOSS⁩ #ipc #gimalignancies ⁦@UCLAJCCC⁩ big trials ongoing are the NCT, Alliance, and PRODIGE.
account_circle
Klebanoff_Lab(@KlebanoffLab) 's Twitter Profile Photo

Impressive phase 1 trial results testing a Claudin18.2-specific CAR in patients with R/R . Favorable toxicity profile and correlation between T cell persistence and antitumor efficacy. Nature Medicine

account_circle
PER(@gotoPER) 's Twitter Profile Photo

Last chance to register for PER's live satellite symposium on mCRC! Don't miss out on earning free CE/CME. Register now: bit.ly/3O1Wy70 24

Last chance to register for PER's live satellite symposium on mCRC! Don't miss out on earning free CE/CME. Register now: bit.ly/3O1Wy70 #gotoPER #ASCOGI #GImalignancies #ASCOGI24
account_circle